We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Makers of Combo Products: Anticipate Postapproval Changes
FDA to Makers of Combo Products: Anticipate Postapproval Changes
February 7, 2013
Makers of drug-device combination products are urged to anticipate postapproval changes that they may wish to make and to develop plans for the preparation of revision proposals, new FDA draft guidance says.